Ozempic is a brand name for the medication semaglutide, used primarily to improve blood glucose control in adults with type 2 diabetes
Frequent shortages have also prompted a booming gray market for compounded GLP-1s, which the FDA has warned can be ineffective and risky
Diabetes, Obesity and Metabolism, 26(4), 765773
Favor SGLT2 inhibitors or a GLP-1 receptor agonist over placebo
Introduction Suppose youve seen the recent addition of semaglutide (brand name Wegovy) to the list of FDA-approved treatments for weight management
Furthermore, previous clinical studies have often suffered from small sample sizes or limited medical databases, thereby restricting their broader generalizability and use as proxies for performance estimates in routine clinical practice